The failure of the investigations above based on 177Lu-labeled exendin-4 to complete GLP-1R molecular imaging and targeted therapy in insulinoma models will present an emerging opportunity for our long-term research. The gene discussed is GLP1R; the disease is pancreatic insulinoma.